Biodel to Present at Upcoming Conferences
DANBURY, Conn., Feb. 4, 2014 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD)
announced today that it will present at the following upcoming conferences:
*February 7, 2014, 1:22 p.m. Central European Time: Biodel will be
presenting "Novel Formulations to Modify Mealtime Insulin Kinetics" in the
Mealtime Insulin Industry Session at the 7th International Conference on
Advanced Technologies & Treatments for Diabetes in Vienna, Austria.
Concurrent with the presentation, slides will be available in the News &
Events section of the Biodel website, www.biodel.com
*February 11, 2014, 3:30 p.m. U.S. Eastern Standard Time: Biodel management
will be presenting an overview of the Company's technologies, development
programs, and outlook at the 16th Annual BIO CEO & Investor Conference at
the Waldorf Astoria in New York, NY. Interested parties can access a link
to a live webcast of the presentation from the News & Events section of
the Biodel website, www.biodel.com. Replays of the presentation will be
available for 90 days.
About Biodel Inc.
Biodel Inc. is a specialty biopharmaceutical company focused on the
development and commercialization of innovative treatments for diabetes that
may be safer, more effective and more convenient for patients. Biodel's
product candidates are developed by applying proprietary technologies to
existing drugs in order to improve their therapeutic profiles. More
information about Biodel is available at www.biodel.com.
CONTACT: John Graziano, +1 (646) 378 2942
Press spacebar to pause and continue. Press esc to stop.